apollo
0
Reviewed By , MPharma., PhD
Last Updated Jan 1, 2025 | 9:32 AM IST

Bavencio 200 mg Infusion is an anti-cancer medicine used in the treatment of different types of cancer. It contains Avelumab, a type of immunotherapy called a checkpoint inhibitor. It blocks proteins that stop the immune system from attacking the cancer cells; this allows the immune cells to kill the cancer cells. Bavencio 200 mg Infusion may cause side effects such as diarrhoea, nausea, vomiting, tiredness, itching, rash, headache, fever, shortness of breath, muscle/joint pain, loss of appetite and injection site reactions.

Read more
Prescription drug

Whats That

tooltip
Consult Doctor

Composition :

AVELUMAB-200MG

Manufacturer/Marketer :

Merck Ltd

Consume Type :

PARENTERAL

Return Policy :

3 Days Returnable

Expires on or after :

Jan-27

About Bavencio 200 mg Infusion

Bavencio 200 mg Infusion is an anti-cancer medicine used in the treatment of different types of cancer. Cancer is a disease where the cells grow abnormally and divide uncontrollably. This medicine is used in treating Merkel cell carcinoma as first-line therapy in combination with axitinib in patients with renal cell carcinoma and in patients with advanced or metastatic urothelial carcinoma that has not progressed with first-line platinum-containing chemotherapy.

Bavencio 200 mg Infusion contains Avelumab, which functions by binding to PD-L1 specifically and preventing it from interacting with PD-1 proteins, thereby prevents the immune system from fighting cancer cells and enables the immune cells to kill the cancer cells.

Bavencio 200 mg Infusion may cause certain side effects such as diarrhoea, nausea, vomiting, tiredness, itching, rash, headache, fever, shortness of breath, muscle/joint pain, loss of appetite and injection site reactions. Inform your doctor if any of these side effects persist for longer. Bavencio 200 mg Infusion will be administered by an oncologist trained in administering anti-cancer agents. 

Avoid receiving Bavencio 200 mg Infusion and inform your doctor if you are allergic to it or any other components of it. Before taking Bavencio 200 mg Infusion, tell your doctor if you have/had liver or kidney disease, autoimmune disorders such as ulcerative colitis or Crohn's disease, a history of organ transplants, heart problems, lung disease, and breathing difficulty. This medicine is known to cause embryo-fetal toxicity. Hence, it is not recommended for use in pregnancy. Avoid breastfeeding while taking Bavencio 200 mg Infusion.

Uses of Bavencio 200 mg Infusion

Treatment of Merkel cell carcinoma, Renal cell carcinoma and Urothelial carcinoma

Medicinal Benefits

Bavencio 200 mg Infusion contains Avelumab, which is used in the treatment of different types of cancers. It works by binding to PD-L1 selectively, blocking its interaction with PD-1, the inhibitory T-cell receptor. T-cell-mediated, adaptive antitumour immune responses are produced when PD-L1 inhibition eliminates the suppression of T-cell activity. It blocks its interaction with PD-1 proteins that stop the immune system from attacking the cancer cells; this allows the immune cells to kill the cancer cells.

Side Effects of Bavencio 200 mg Infusion

  • Nausea
  • Vomiting
  • Diarrhoea
  • Loss of appetite
  • Weakness
  • Muscle pain
  • Cough
  • Headache
  • Fever
  • Itching
  • Rash
  • Back pain
  • Upper respiratory tract infections
  • Injection site reactions

Directions for Use

Bavencio 200 mg Infusion will be administered by a trained oncologist in the hospital setting. Hence, do not self-administer. Your doctor will decide the dose and duration of the treatment based on the severity and type of cancer.

Storage

Store in a cool and dry place away from sunlight

Drug Warnings

To treat your condition effectually, continue receiving Bavencio 200 mg Infusion for the period that your doctor has prescribed. Bavencio 200 mg Infusion may cause severe immune-mediated adverse reactions (IMAR) such as immune-mediated colitis, hepatitis, hepatotoxicity, nephritis, endocrinopathies, pneumonitis, cardiac problems, and dermatologic reactions. It may also cause infusion-related reactions in some patients. Therefore, caution should be exercised if you have/had liver or kidney disease, any history of organ transplant, gastrointestinal disorders, autoimmune disorders such as ulcerative colitis or Crohn’s disease, lung disease, heart problems, and breathing difficulty while receiving Bavencio 200 mg Infusion. This medicine may also cause severe infusion-related reactions. Hence, careful monitoring is recommended and discontinue the treatment if any severe infusion reactions occur. Inform your doctor if you are pregnant or are planning to become pregnant before starting the treatment, as this medicine is known to cause embryo-fetal toxicity. Breastfeeding should be discontinued in nursing mothers during the treatment as it passes into breast milk and may cause a possible risk to the infant. This medicine is not recommended for use in children below 12 years of age as the safety and efficacy are not established.

Therapeutic Class

ANTINEOPLASTIC

Diet & Lifestyle Advise

  • Physical activity helps strengthen muscles, reduces fatigue, helps in weight loss, and gives strength. Gentle activities like 20-30 minutes of walking or swimming would be helpful.
  • Maintain a healthy weight by performing regular low-strain exercises and eating healthy food.
  • Getting adequate sleep as resting helps improve your health and mental ability and improves attention.
  • De-stress yourself by meditating, reading books, taking a warm bubble bath, or listening to soothing music.
  • Eat food rich in antioxidants such as berries, spinach, etc.
  • Foods containing fibre help in better digestion. These include beans, peas, lentils, whole grains, nuts, and seeds.
  • Avoid smoking and alcohol consumption.
  • Maintain a healthy weight.

Habit Forming

No

How Bavencio 200 mg Infusion Works

Bavencio 200 mg Infusion contains Avelumab, which functions by binding to PD-L1 specifically and preventing it from interacting with PD-1 proteins, thereby prevents the immune system from fighting cancer cells and enables the immune cells to kill the cancer cells.

What if I have taken an overdose of Bavencio 200 mg Infusion

As Bavencio 200 mg Infusion is a parenteral formulation administered by experienced medical staff, the chance of overdose may be less. However, if you think there has been an overdose or experiencing any adverse events, get medical care right away.
bannner image

Alcohol

Consult your doctor

It is unknown whether Bavencio 200 mg Infusion interacts with alcohol. Consult your doctor for more information.

bannner image

Pregnancy

Unsafe

Bavencio 200 mg Infusion is not recommended for use in pregnancy as it may cause embryo-fetal toxicity and harm your foetus. Hence, if you are pregnant or planning pregnancy, inform your doctor before receiving Bavencio 200 mg Infusion. You should not become pregnant while you are receiving Bavencio 200 mg Infusion for at least one month from the last dose of Bavencio 200 mg Infusion. Using effective birth control methods while on treatment is suggested.

bannner image

Breast Feeding

Unsafe

Bavencio 200 mg Infusion should not be taken if you are breastfeeding as it passes into breast milk and may harm your infant. Avoid nursing your child while on treatment with this medicine and for at least one month from the last dose of medicine.

bannner image

Driving

Not applicable

Bavencio 200 mg Infusion will be administered to hospitalized patients.

bannner image

Liver

Caution

If you have a pre-existing or a history of liver problems, tell your doctor before receiving this medicine. Inform your doctor if you experience any symptoms, such as severe nausea or vomiting, right-sided upper stomach pain, easy bruising or bleeding, dark urine, or jaundice (yellowing of the skin or eyes). Your doctor may suggest tests to monitor your liver function while on treatment with this medicine.

bannner image

Kidney

Caution

If you have a pre-existing or a history of kidney diseases, inform your doctor before receiving Bavencio 200 mg Infusion. Tell your doctor if you have little or no urination, swelling in your feet or ankles, or blood in your urine. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.

bannner image

Children

Unsafe

Bavencio 200 mg Infusion is not recommended for use in children below 12 years as the safety and efficacy are not established.

Country of origin

India

Manufacturer/Marketer address

L-2, J.R. Complex, Gate No. 4, Village Mandoli, Delhi-110 093, India
Other Info - BAV0001

Author Details

Doctor imageWe provide you with authentic, trustworthy and relevant information

FAQs

Bavencio 200 mg Infusion is used to treat Merkel cell carcinoma, Renal cell carcinoma and Urothelial carcinoma.
Bavencio 200 mg Infusion contains Avelumab, which works by inhibiting the action of a programmed death receptor-1 (PD-L1) that causes the multiplication of cancerous cells.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
icon image

Keep Refrigerated. Do not freeze.

whatsapp Floating Button

Add to Cart